register free | resend password


VSY Biotechnology Announce the Winners of 2020 Ophthalmology Star Awards (OSA)

ID: 1562320
recent pressrelease next pressrelease

(PresseBox) - VSY Biotechnology GmbH, an innovation-driven company with progressive R&D activities in ophthalmology, has announced the winners of the 2020 Ophthalmology Star Awards.

This year?s ?Ophthalmology Star Award? is dedicated to Dr. Li Wenliang, an

an ophthalmologist who was the first to raise the alarm about COVID-19.

Ophthalmologists applied for the contest with their articles until September 18, 2020, from the OSA page. (https://www.vsybiotechnology.com/starawards/) on the VSY Biotechnology

website. Their articles must have been published in a scientific journal as of January 2019. The OSA team received applications from all around the world. Three ophthalmologists are awarded ranks based upon their scientific research?s usefulness for the clinical ophthalmologist, novelty, and readability of the paper.

First place winner: Dr. Rupesh Agrawal ? Singapore

Clinical study title:

Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis.

Second place winner: Dr. David Lockington ? UK

Clinical study title:

Third place winner: Dr. Dasha Elena Nelidova ? Switzerland

Clinical study title:

To learn more about the award winners and to gain insight into their working practices, please visit the VSY Biotechnology website (https://www.vsybiotechnology.com/starawards/), where you can access the winners? articles.

VSY Biotechnology GmbH is an innovation-driven company with progressive R&D activities in ophthalmology, orthopedics, aesthetics, and biotechnological drugs. VSY Biotechnology focuses on developing, designing, and manufacturing superior state-of-the-art products to serve doctors, patients, and consumers beyond their expectations.



More information:
http://https://



Keywords (optional):



Company information / Profile:

VSY Biotechnology GmbH is an innovation-driven company with progressive R&D activities in ophthalmology, orthopedics, aesthetics, and biotechnological drugs. VSY Biotechnology focuses on developing, designing, and manufacturing superior state-of-the-art products to serve doctors, patients, and consumers beyond their expectations.

PressRelease by

Requests:



PressContact / Agency:



published by: PresseBox
print pressrelease  send to a friend  

Date: 11/17/2020 - 10:46
Language: English
News-ID 1562320
Character count: 2120
Kontakt-Informationen:
Firma: VSY Biotechnology GMBH
Ansprechpartner: Feedback to businesspress24.com about Pressrelease-id:
Stadt: Leinfelden-Echterdingen, Germany
Telefon:

Meldungsart:
Versandart:
Freigabedatum:
Comments:



Number of hits: 926

Linking-Tips:



Direct Link to this PressRelease:






We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease






All members: 9 438
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 62


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.